The following data is part of a premarket notification filed by Asuragen, Inc. with the FDA for Rnaretain.
| Device ID | K113420 | 
| 510k Number | K113420 | 
| Device Name: | RNARETAIN | 
| Classification | Tissue Rna Preservative For Collection, Storage, And Transportation | 
| Applicant | ASURAGEN, INC. 2150 WOODWARD ST. SUITE 100 Austin, TX 78744 -1840 | 
| Contact | Luc Van Hove | 
| Correspondent | Luc Van Hove ASURAGEN, INC. 2150 WOODWARD ST. SUITE 100 Austin, TX 78744 -1840 | 
| Product Code | OZF | 
| CFR Regulation Number | 866.4070 [🔎] | 
| Decision | Substantially Equivalent (SESE) | 
| Type | Traditional | 
| 3rd Party Reviewed | No | 
| Combination Product | No | 
| Date Received | 2011-11-18 | 
| Decision Date | 2012-03-16 | 
| Summary: | summary | 
| Device Identifier | submissionNumber | Supplement | 
|---|---|---|
| 00863840000285 | K113420 | 000 | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  RNARETAIN  77209982  3689865 Live/Registered | Asuragen, Inc. 2007-06-19 |